I

Intuitive Surgical

Builds robots for minimally invasive surgery

Thermal Design Engineer 3

Full-TimeUpdated on 10/23/2026
$115.7k - $195.9k
Mid
Bachelor's
Sunnyvale, CA, USA
In PersonTravel up to 10% of the time; preference given to applicants outside the listed states.
Mechanical EngineeringThermal & Fluids Engineering

About the job

Requirements
  • A Bachelor of Science degree in Mechanical Engineering, Thermal Sciences, Physics, or a related field.
  • At least 3 years of experience in thermal engineering, electronics cooling, computational fluid dynamics, or thermal test and validation.
  • Strong understanding of heat transfer, fluid mechanics, airflow, and thermal management.
  • Experience with computational fluid dynamics tools such as ANSYS Icepak, FloTHERM, FLOEFD, Fluent, or similar.
  • Experience with thermal testing, instrumentation, and model correlation.
  • Direct experience with heat sinks, heat pipes, vapor chambers, thermal interface materials, fans, and high-power electronics cooling.
  • Familiarity with advanced thermal materials and technologies.
  • Proficiency in SolidWorks, CATIA, or equivalent computer-aided design tools.
  • Ability to travel up to 10% of the time.
  • Strong problem-solving skills and the ability to collaborate across functions.
  • Ability to manage multiple projects and shifting priorities in ambiguous, fast-paced development environments.
  • Preference is given to qualified candidates who do not reside or plan to reside in Alabama, Arkansas, Delaware, Florida, Indiana, Iowa, Louisiana, Maryland, Mississippi, Missouri, Oklahoma, Pennsylvania, South Carolina, or Tennessee.
Responsibilities
  • Own thermal design, analysis, testing, performance, and compliance across vision hardware products and systems.
  • Develop thermal solutions, including airflow management, heat sinks, heat pipes, vapor chambers, thermal interface materials, and active cooling systems.
  • Create analytical, computational fluid dynamics, and finite element analysis thermal models and correlate results with laboratory testing.
  • Plan and execute thermal characterization, validation, accelerated life testing, and model correlation activities.
  • Define thermal limits, derating strategies, and protection approaches with electrical and software teams.
  • Specify and qualify thermal components and collaborate with suppliers.
  • Leverage and manage external engineering resources and contractors as needed to supplement internal capacity.
  • Create and review computer-aided design designs, drawings, assemblies, tolerances, and related documentation.
  • Partner with mechanical, optical, electrical, systems, software, and manufacturing teams.
  • Support design for manufacturing and design for assembly activities to ensure successful transfer from development to production.
  • Deliver thermally robust, compliant products with appropriate performance margin.
  • Translate ambiguous requirements into practical thermal solutions and validated designs.
  • Connect simulation, testing, computer-aided design, and manufacturing constraints to drive decisions.
  • Serve as the trusted thermal engineering expert across multiple Vision Hardware programs.
  • Contribute to broader mechanical and opto-mechanical design efforts when required.
Desired Qualifications
  • Programming experience with Python, MATLAB, or similar scripting languages.
  • Demonstrated use of artificial intelligence tools to improve engineering workflows and productivity.
  • Prior experience with Design Control processes for medical devices and clinical application of surgical instruments.
  • Prior experience with Agile Change Control and SAP.

About the company

Intuitive Surgical makes da Vinci robots that let surgeons operate through a few small incisions, and Ion, a robot that reaches deep into the lungs to take tissue samples. In 2000, da Vinci became the first robotic system cleared by the FDA for general laparoscopic surgery, meaning keyhole operations in the abdomen. A surgeon sits at a nearby console and steers robotic arms holding a 3D camera and wristed instruments, which turn hand movements into smaller, steadier motions. Hospitals buy or lease the robots, then keep paying for the instruments used in each operation and for service. Intuitive was founded in 1995 to commercialize robotic surgery research from SRI International and is based in Sunnyvale, California.

Company Size

10,001+

Company Stage

IPO

Headquarters

Sunnyvale, California

Founded

1995

Get referred to Intuitive Surgical

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Demand keeps compounding: da Vinci procedures grew 15% and revenue 19%, to $2.89 billion, in the June 2026 quarter.
  • Room to grow: Intuitive listed 748 open roles in October 2026, including 191 in engineering and 312 in Sunnyvale.
  • Repeat sales steady the business: instruments and service made 76% of revenue in the June 2026 quarter.

What critics are saying

  • Stock grants have shrunk: shares fell 27% from January to October 2026, versus 9% for rival Medtronic.
  • Device giants are moving in: the FDA cleared rival robots from Medtronic in December 2025 and J&J in July 2026.
  • Instrument sales face a court fight: in August 2026, an appeals court revived a repair firm's monopoly suit against Intuitive.

What makes Intuitive Surgical unique

  • Hospitals rent more than they buy: 254 of 468 da Vinci systems placed in the June 2026 quarter were leases.
  • It runs without borrowing: Intuitive had no debt and $8.6 billion in cash and investments in June 2026.
  • Its CEO is a 30-year insider: Dave Rosa, CEO since July 2025, joined as employee number nine in 1996.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Hybrid Work Options

Growth & Insights and Company News

6 month growth

0%

1 year growth

0%

2 year growth

0%
LinkedIn
Oct 25th, 2026
Ruby Robotics Acquired by Intuitive for Minimally Invasive Care Solutions | Ruby Robotics posted on the topic | LinkedIn

We are excited to announce that in late 2025, Ruby Robotics was acquired by Intuitive, a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery.   Together with Intuitive, we are continuing our mission to improve the accuracy, efficiency, and accessibility of tissue assessment during biopsy procedures at the point of care with integrated robotics and artificial intelligence solutions.   Thank you to our team, investors, advisors, consultants, and contributors whose shared belief in our vision made Ruby a success. To our new Intuitive colleagues: we’re excited to collaborate with you and look forward to making a positive impact on patients and physicians together. E14 Fund Root Ventures Link Ventures SeedFolio Kicker Ventures Celtic House Asia Partners Zelda Ventures Tamer Capital Taiwan Global Angels Cendana Capital UNION | 19 comments on LinkedIn

Yahoo Finance
Oct 1st, 2026
Intuitive Surgical down 30% in 2026, but Wall Street analysts stay bullish

Intuitive Surgical has lost nearly 30% year-to-date in 2026, making it one of healthcare's biggest losers. The stock fell over 40% by late July. Despite this decline, Wall Street remains bullish—24 of 32 analysts surveyed by S&P Global in September rated it a "buy" or "strong buy." The medical device maker faces several challenges. Growth is slowing whilst the stock trades at a forward price-to-earnings multiple over 33. Competition in China remains difficult, and the company now battles healthcare giants Johnson & Johnson, Medtronic, and Stryker in robotic surgical systems. The expiration of Affordable Care Act subsidies and rising GLP-1 drug usage have also impacted procedure volumes. However, the company's Asian revenue still jumped 20% year-over-year in Q2, suggesting these headwinds aren't insurmountable.

Yahoo Finance
Sep 17th, 2026
Intuitive Surgical, IonQ, and Accenture hold billions in net cash for growth

Investors seeking financial stability often look to companies with more cash than debt, as these businesses have greater flexibility for growth investments, buybacks, and dividends. Intuitive Surgical holds $5.22 billion in net cash. The robotic surgery pioneer achieved 20.7% annual revenue growth over the past two years, whilst its earnings per share increased 17.4% annually over five years. IonQ maintains $2.06 billion in net cash, representing 14.1% of its market capitalisation. The quantum computing company posted 181% annual revenue growth over two years and expects 163% growth next year. Accenture has $1.78 billion in net cash. The professional services firm employs approximately 774,000 people across more than 120 countries. Companies with strong balance sheets can navigate uncertain markets whilst pursuing expansion opportunities without the burden of significant debt obligations.

Yahoo Finance
Aug 23rd, 2026
Thermo Fisher vs Intuitive Surgical: which premium healthcare stock justifies valuation?

Thermo Fisher and Intuitive Surgical both delivered strong recent quarters, but their premium valuations rest on different foundations. Thermo Fisher's case depends on recovery in life sciences spending after the pandemic slowdown. The company's Life Sciences Solutions segment saw reported revenue climb 13% year-over-year, with organic revenue up 3%. The Analytical Instruments business returned to growth after nearly two years of weak demand, suggesting laboratory spending is normalising. Intuitive Surgical maintains its premium through business model strength. The company's non-GAAP gross profit margin reached 70.0%, whilst its non-GAAP operating margin expanded 330 basis points year-over-year to 42.1%. Recurring revenue streams constitute roughly 85% of total sales. Intuitive placed 468 da Vinci surgical units in fiscal Q2, marking 18% year-over-year growth, indicating continued hospital investment in robotic surgery platforms.

Yahoo Finance
Aug 19th, 2026
Abbott beats Q2 estimates with 13% sales growth as diagnostics surge 42%, while Intuitive Surgical posts 19% revenue rise

Abbott Laboratories reported strong fiscal Q2 2026 results, with sales rising 13% on a reported basis and 4.8% on a comparable basis, beating estimates and prompting the company to raise its annual profit forecast. The diagnostics segment was particularly strong, growing 42% to $3.09 billion, driven by its cancer diagnostics business following the Exact Sciences acquisition. Intuitive Surgical also exceeded expectations in Q2 2026, with revenue growing 19% to $2.89 billion and adjusted EPS of $2.80, beating forecasts by $0.30. The company placed 468 da Vinci units during the quarter, an 18% year-over-year increase, whilst maintaining a non-GAAP gross margin of 70.0%. The companies present contrasting investment cases: Abbott offers diversified healthcare portfolio resilience, whilst Intuitive Surgical relies on its robotic surgery ecosystem with recurring revenue comprising approximately 85% of total sales.